Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLIT vs OIT for Peanut Allergy
NCT01084174Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Mar 2010
- Primary completion
- Jan 2012
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of peanut allergen extract in peanut allergy (3 arms), sponsored by Johns Hopkins University. Primary endpoint: Number of Participants With Induced Peanut Desensitization at 12 months. Started Mar 2010; status: completed.
02
Drugs
peanut allergen extract
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT01084174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01084174.